切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (02) : 133 -138. doi: 10.3877/cma.j.issn.2095-3232.2021.02.004

所属专题: 文献

专家论坛

肝门部胆管癌外科治疗进展和争议
陈泰安1, 熊永福2, 杨发才2, 李梦2, 黄徐建2, 李敬东1,()   
  1. 1. 637000 四川省南充市,川北医学院附属医院肝胆外一科;637000 四川省南充市,川北医学院肝胆胰肠研究所
    2. 637000 四川省南充市,川北医学院附属医院肝胆外一科
  • 收稿日期:2021-01-19 出版日期:2021-04-10
  • 通信作者: 李敬东
  • 基金资助:
    四川省教育厅创新团队项目(16TDD0025); 四川省科技厅项目(19YYJC1298)

Research progress and dispute on surgical treatments for intrahepatic cholangiocarcinoma

Taianm Chen1, Yongfu Xiong2, Facai Yang2   

  • Received:2021-01-19 Published:2021-04-10
引用本文:

陈泰安, 熊永福, 杨发才, 李梦, 黄徐建, 李敬东. 肝门部胆管癌外科治疗进展和争议[J]. 中华肝脏外科手术学电子杂志, 2021, 10(02): 133-138.

Taianm Chen, Yongfu Xiong, Facai Yang. Research progress and dispute on surgical treatments for intrahepatic cholangiocarcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(02): 133-138.

[1]
de Jong MC, Marques H, Clary BM, et al. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases[J]. Cancer, 2012, 118(19):4737-4747.
[2]
Nassour I, Mokdad AA, Porembka MR, et al. Adjuvant therapy is associated with improved survival in resected perihilar cholangiocarcinoma: a propensity matched study[J]. Ann Surg Oncol, 2018, 25(5):1193-1201.
[3]
Liu CL, Fan ST, Lo CM, et al. Improved operative and survival outcomes of surgical treatment for hilarcholangiocarcinoma[J]. Br J Surg, 2006, 93(12):1488-1494.
[4]
Lee SG, Song GW, Hwang S, et al. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience[J].J Hepatobiliary Pancreat Sci, 2010, 17(4):476-489.
[5]
Chen RX, Li CX, Luo CH, et al. Surgical strategies for the treatment of Bismuth type Ⅰ and Ⅱ hilar cholangiocarcinoma: bile duct resection with or without hepatectomy?[J]. Ann Surg Oncol, 2020, 27(9):3374-3382.
[6]
Chen XP, Lau WY, Huang ZY, et al. Extent of liver resection for hilar cholangiocarcinoma[J]. Br J Surg, 2009, 96(10):1167-1175.
[7]
Ikeyama T, Nagino M, Oda K, et al. Surgical approach to bismuth type Ⅰ and Ⅱ hilar cholangiocarcinomas: audit of 54 consecutive cases[J]. Ann Surg, 2007, 246(6):1052-1057.
[8]
Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portalvein embolization[J]. Ann Surg, 2003, 238(1):84-92.
[9]
Sugiura T, Okamura Y, Ito T, et al. Left hepatectomy with combined resection and reconstruction of right hepatic artery for Bismuth type Ⅰ and Ⅱ perihilar cholangiocarcinoma.[J]. World J Surg, 2019, 43(3): 894-901.
[10]
Lee Y, Choi D, Han S, et al. Comparison analysis of left-side versus right-side resection in bismuth type Ⅲ hilar cholangiocarcinoma[J]. Ann Hepatobiliary Pancreat Surg, 2018, 22(4):350-358.
[11]
Ebata T, Mizuno T, Yokoyama Y, et al. Surgical resection for Bismuth type Ⅳ perihilar cholangiocarcinoma[J]. Br J Surg, 2018, 105(7): 829-838.
[12]
Matsumoto N, Ebata T, Yokoyama Y, et al. Role of anatomical right hepatic trisectionectomy for perihilar cholangiocarcinoma[J]. Br J Surg, 2014, 101(3):261-268.
[13]
Zaydfudim VM, Rosen CB, Nagorney DM. Hilar cholangiocarcinoma[J]. Surg Oncol Clin N Am, 2014, 23(2):247-263.
[14]
Dumitrascu T, Brasoveanu V, Stroescu C, et al. Major hepatectomies for perihilar cholangiocarcinoma: predictors for clinically relevant postoperative complications using the International Study Group of Liver Surgery definitions[J]. Asian J Surg, 2016, 39(2):81-89.
[15]
Bhutiani N, Scoggins CR, McMasters KM, et al. The impact of caudate lobe resection on margin status and outcomes in patientswith hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium[J]. Surgery, 2018, 163(4):726-731.
[16]
Juntermanns B, Kaiser GM, Reis H, et al. Long-term survival after resection for perihilar cholangiocarcinoma: impact of UICC staging and surgical procedure[J]. Turk J Gastroenterol, 2019, 30(5):454-460.
[17]
Chen W, Ke K, Chen YL. Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis[J]. Eur J Surg Oncol, 2014, 40(5):489-495.
[18]
Schimizzi GV, Jin LX, Davidson 4th JT, et al. Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium[J]. HPB, 2018, 20(4): 332-339.
[19]
Hemming AW, Mekeel K, Khanna A, et al. Portal vein resection in management of hilar cholangiocarcinoma[J]. J Am Coll Surg, 2011, 212(4):604-613.
[20]
Takahashi Y, Nagino M, Nishio H, et al. Percutaneous transhepatic biliary drainage catheter tract recurrence incholangiocarcinoma[J]. Br J Surg, 2010, 97(12):1860-1866.
[21]
Komaya K, Ebata T, Yokoyama Y, et al. Verification of the oncologic inferiority of percutaneous biliary drainage toendoscopic drainage: a propensity score matching analysis of resectable perihilar cholangiocarcinoma[J]. Surgery, 2017, 161(2):394-404.
[22]
Yamashita H, Ebata T, Yokoyama Y, et al. Pleural dissemination of cholangiocarcinoma caused by percutaneous transhepatic biliary drainage during the management of resectable cholangiocarcinoma[J]. Surgery, 2019, 165(5):912-917.
[23]
Al Mahjoub A, Menahem B, Fohlen A, et al. Preoperative biliary drainage in patients with resectable perihilar cholangiocarcinoma: is percutaneous transhepatic biliary drainage safer and more effective than endoscopic biliary drainage? a meta-analysis[J]. J Vasc Interv Radiol, 2017, 28(4):576-582.
[24]
Tang Z, Yang Y, Meng W, et al. Best option for preoperative biliary drainage in Klatskin tumor: a systematic review and meta-analysis[J]. Medicine, 2017, 96(43):e8372.
[25]
Kawashima H, Itoh A, Ohno E, et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy andrisk factors related to complications[J]. Ann Surg, 2013, 257(1): 121-127.
[26]
Kawakami H, Kuwatani M, Onodera M, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma[J].J Gastroenterol, 2011, 46(2):242-248.
[27]
Liu F, Li Y, Wei Y, et al. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? a systematic review[J]. Dig Dis Sci, 2011, 56(3):663-672.
[28]
Coelen RJS, Ruys AT, Besselink MGH, et al. Diagnostic accuracy of staging laparoscopy for detecting metastasized or locally advanced perihilar cholangiocarcinoma: a systematic review and meta-analysis[J]. Surg Endosc, 2016, 30(10):4163-4173.
[29]
Bird N, Elmasry M, Jones R, et al. Role of staging laparoscopy in the stratification of patients with perihilar cholangiocarcinoma[J]. Br J Surg, 2017, 104(4):418-425.
[30]
Hu H, Wu Z, Jin Y, et al. Minimally invasive surgery for hilar cholangiocarcinoma: state of art and future perspectives[J]. ANZ J Surg, 2019, 89(5):476-480.
[31]
Lin E, Sarmiento JM. Laparoscopic extended right hepatectomy, portal lymphadenectomy, and hepaticojejunostomy for hilar cholangiocarcinoma[J]. J Laparoendosc Adv Surg Tech A, 2014, 24(6):411-416.
[32]
腹腔镜肝门部胆管癌根治切除术操作规范专家组,中华外科杂志编辑部. 腹腔镜肝门部胆管癌根治性切除操作流程专家建议[J]. 中华外科杂志,2019,57(8):561-567.
[33]
Sudan D, DeRoover A, Chinnakotla S, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma[J]. Am J Transplant, 2002, 2(8):774-779.
[34]
Ethun CG, Lopez-Aguiar AG, Anderson DJ, et al. Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease[J]. Ann Surg, 2018, 267(5):797-805.
[35]
Moris D, Kostakis ID, Machairas N, et al. Comparison between liver transplantation and resection for hilar cholangiocarcinoma:a systematic review and meta-analysis[J]. PLoS One, 2019, 14(7): e220527.
[36]
Hong JC, Jones CM, Duffy JP, et al. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma[J]. Arch Surg, 2011, 146(6):683-689.
[37]
Dondorf F, Uteß F, Fahrner R, et al. Liver transplant for perihilar cholangiocarcinoma (Klatskin tumor): the essential role of patient selection[J]. Exp Clin Transplant, 2019, 17(3):363-369.
[1] 李凯, 陈淋, 向涵, 苏怀东, 张伟. 一种U型记忆合金线在经脐单孔腹腔镜阑尾切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 15-15.
[2] 曹迪, 张玉茹. 经腹腔镜生物补片修补直肠癌根治术后盆底疝1例[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 115-116.
[3] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[4] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[5] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[6] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[7] 李晓玉, 江庆, 汤海琴, 罗静枝. 围手术期综合管理对胆总管结石并急性胆管炎患者ERCP +LC术后心肌损伤的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 57-60.
[8] 甄子铂, 刘金虎. 基于列线图模型探究静脉全身麻醉腹腔镜胆囊切除术患者术后肠道功能紊乱的影响因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 61-65.
[9] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[10] 莫波, 王佩, 王恒, 何志军, 梁俊, 郝志楠. 腹腔镜胃癌根治术与改良胃癌根治术治疗早期胃癌的疗效[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 644-647.
[11] 鲁鑫, 许佳怡, 刘洋, 杨琴, 鞠雯雯, 徐缨龙. 早期LC术与PTCD续贯LC术治疗急性胆囊炎对患者肝功能及预后的影响比较[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 648-650.
[12] 孟飞龙, 华帅, 张莹, 路广海. 经脐单孔腹腔镜后鞘后入路在全腹膜外腹股沟疝修补术中的应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 658-660.
[13] 阿冲罗布, 陈颖, 谢德坤. 腹腔镜外囊完整剥离术治疗肝包虫病效果及对患者肝功能、预后的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 666-669.
[14] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[15] 程相阵. 腹茧症9例诊治分析并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(9): 968-971.
阅读次数
全文


摘要